Delivery Order SPE2DB24D1021-SPE2DB25FEVMC

Award Date 4/2/25
Potential Completion Date 4/3/25
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $13,538.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, and has an ultimate completion date of July 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,039.74, and has an ultimate completion date of January 21, 2025. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $48,931.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of January 14, 2025. The award is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. This contract is not designated with a Set-Aside requirement, indicating open...
This federal contract award, valued at $6,733.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a completion date of January 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,080.28, is for the delivery of TRIUMEQ 600-50-300 MG TABLET medication. The contract is a Firm Fixed Price Delivery Order that runs through November 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and expiring in...
This federal contract award, valued at $34,901.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that provides the DLA with TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, under a Firm Fixed Price pricing structure. The contract has an ultimate completion date of November 7, 2024. This contract award is associated with a larger Indefinite Delivery...
This federal contract award, valued at $19,997.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide TRIUMEQ 600-50-300 MG TABLET (a specialty medication) valued at $21,656.33. The contract is a Firm Fixed Price Delivery Order with a completion date of January 3, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $9,044.70 firm fixed-price contract is for the supply of TRIUMEQ 600-50-300 MG TABLET medical products with a completion date of February 14, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the supply of TRIUMEQ 600-50-300 MG TABLET medication. The contract, valued at $17,202.38, is a delivery order issued under an existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FEVMC
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of TRIUMEQ 600-50-300 MG TABLET in a quantity of 30s. The contract has a firm fixed price of $24,292.72 and an ultimate completion date of April 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/2/25, 11:03 PM